Development of an Enzyme-linked Immunosorbent Spot Assay to Measure Serum-neutralizing Antibodies Against Coxsackievirus B3

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2014 Jan 7

PMID 24391137

Citations 7

Authors

Lisheng Yang

Delei He

Min Tang

Zhiqun Li

Che Liu

Longfa Xu

Yixin Chen

Hailian Du

Qinjian Zhao

Jun Zhang

Tong Cheng

Ningshao Xia

Affiliations

Soon will be listed here.

Abstract

Coxsackievirus B3 (CVB3) is the most common pathogen that induces acute and chronic viral myocarditis in children. The cytopathic effect (CPE)-based neutralization test (Nt-CPE) and the plaque reduction neutralization test (PRNT) are the most common methods for measuring neutralizing antibody titers against CVB3 in blood serum samples. However, these two methods are inefficient for CVB3 vaccine clinical trials, which require the testing of a large number of serum specimens. In this study, we developed an efficient neutralization test based on the enzyme-linked immunospot (Nt-ELISPOT) assay for measuring CVB3-neutralizing antibodies. This modified ELISPOT assay was based on the use of a monoclonal antibody against the viral capsid protein VP1 to detect the cells that are infected with CVB3, which, after immunoperoxidase staining, are counted as spots using an automated ELISPOT analyzer. Using the modified ELISPOT assay, we characterized the infection kinetics of CVB3 and divided the infection process of CVB3 on a cluster of cells into four phases. The stability of the Nt-ELISPOT was then evaluated. We found that over a wide range of infectious doses (10(2) to 10(6.5)× 50% tissue culture infectious dose [TCID(50)] per well), the neutralizing titers of the sera were steady as long as they were tested during the log phase or the first half of the stationary phase of growth of the spots. We successfully shortened the testing period from 7 days to approximately 20 h. We also found that there was a good correlation (R(2) = 0.9462) between the Nt-ELISPOT and the Nt-CPE assays. Overall, the Nt-ELISPOT assay is a reliable and efficient method for measuring neutralizing antibodies in serum.

Citing Articles

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology.

Vaidya S Viruses. 2023; 15(4).

PMID: 37112919 PMC: 10143445. DOI: 10.3390/v15040939.

Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay.

Zhou Z, Zhu R, Yang H, Xu L, Chen H, Wu Y Front Microbiol. 2022; 13:983656.

PMID: 36212859 PMC: 9539532. DOI: 10.3389/fmicb.2022.983656.

Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population.

Zhu R, Cheng T, Yin Z, Liu D, Xu L, Li Y Emerg Microbes Infect. 2018; 7(1):2.

PMID: 29323107 PMC: 5837151. DOI: 10.1038/s41426-017-0003-z.

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.

Luo Y, Xiong D, Li H, Qiu S, Lin C, Chen Q Virol J. 2016; 13:44.

PMID: 26987753 PMC: 4797254. DOI: 10.1186/s12985-016-0508-4.

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3.

Chen P, Wu X, Mao Q, Gao F, Hao X, Bian L J Virol Methods. 2016; 232:1-7.

PMID: 26947399 PMC: 7113863. DOI: 10.1016/j.jviromet.2016.02.010.

References

Huang M, Chiang P, Luo S, Liou G, Lee M . Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. J Virol Methods. 2009; 165(1):42-5. DOI: 10.1016/j.jviromet.2009.12.015. View

Ma J, Hikmat B, Wycoff K, Vine N, Chargelegue D, Yu L . Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med. 1998; 4(5):601-6. DOI: 10.1038/nm0598-601. View

Ivanov A, Dragunsky E . ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev Vaccines. 2005; 4(2):167-72. DOI: 10.1586/14760584.4.2.167. View

Chen Y, Li C, He D, Cheng T, Ge S, Wai-Kuo Shih J . Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2012; 31(2):425-30. DOI: 10.1016/j.vaccine.2012.10.032. View

COATES H, Alling D, Chanock R . An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966; 83(2):299-313. DOI: 10.1093/oxfordjournals.aje.a120586. View

Zielinska E, Liu D, Wu H, Quiroz J, Rappaport R, Yang D . Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis. Virol J. 2005; 2:84. PMC: 1308871. DOI: 10.1186/1743-422X-2-84. View

Haarmann C, Schwimmbeck P, Mertens T, Schultheiss H, Strauer B . Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology. 1994; 200(2):381-9. DOI: 10.1006/viro.1994.1202. View

Kraus A, Messer W, Haymore L, de Silva A . Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol. 2007; 45(11):3777-80. PMC: 2168473. DOI: 10.1128/JCM.00827-07. View

McKinney Jr R, Katz S, Wilfert C . Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987; 9(2):334-56. DOI: 10.1093/clinids/9.2.334. View

10.

DULBECCO R, Vogt M, Strickland A . A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology. 1956; 2(2):162-205. DOI: 10.1016/0042-6822(56)90017-4. View

11.

Rey F, Barre-Sinoussi F, Schmidtmayerova H, Chermann J . Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. J Virol Methods. 1987; 16(3):239-49. DOI: 10.1016/0166-0934(87)90008-5. View

12.

Abai A, Smith L, Wloch M . Novel microneutralization assay for HCMV using automated data collection and analysis. J Immunol Methods. 2007; 322(1-2):82-93. PMC: 1933494. DOI: 10.1016/j.jim.2007.02.001. View

13.

Yoon J, Austin M, Onodera T, Notkins A . Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979; 300(21):1173-9. DOI: 10.1056/NEJM197905243002102. View

14.

Earl P, Americo J, Moss B . Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. J Virol. 2003; 77(19):10684-8. PMC: 228521. DOI: 10.1128/jvi.77.19.10684-10688.2003. View

15.

Pierson T, Sanchez M, Puffer B, Ahmed A, Geiss B, Valentine L . A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology. 2005; 346(1):53-65. DOI: 10.1016/j.virol.2005.10.030. View

16.

Dimmock N . Neutralization of animal viruses. Curr Top Microbiol Immunol. 1993; 183:1-149. DOI: 10.1007/978-3-642-77849-0. View

17.

Arya S, Agarwal N . Poliovirus neutralization test with poliovirus pseudovirus to measure neutralizing antibody in humans. Clin Vaccine Immunol. 2012; 19(3):458. PMC: 3294615. DOI: 10.1128/CVI.05568-11. View

18.

Nara P, Hatch W, Dunlop N, Robey W, Arthur L, Gonda M . Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses. 1987; 3(3):283-302. DOI: 10.1089/aid.1987.3.283. View

19.

Rodrigo W, Alcena D, Rose R, Jin X, Schlesinger J . An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells. Am J Trop Med Hyg. 2009; 80(1):61-5. View

20.

Imrie C, Ferguson J, SOMMERVILLE R . Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut. 1977; 18(1):53-6. PMC: 1411245. DOI: 10.1136/gut.18.1.53. View